We showed that the two most prevalent TFs in SCLC, ASCL1 and NEUROD1, which together are expressed in 70%–85% of SCLC cases8,12, demonstrated strong mutual exclusivity at a cellular resolution. The gene discussed is ASCL1; the disease is small cell lung carcinoma.